Dale R. Tavris, MD, MPH

Risk of Local Adverse Events Following Cardiac Catheterization by Hemostasis Device Use and Gender

08/01/2008

Dale R. Tavris , MD, MPH;

Richard E. Shaw , PhD, FACC;

Beverly Albrecht-Gallauresi , RN, MPH;

Ralph G. Brindis , MD, MPH, FACC;

Ba Lin , MD;

Suzanne E. Rich , RN, MA;

Kathleen Hewitt , MSN, RN, CPHQ;

William S. Weintraub , MD, FACC;

Reports of serious injuries and deaths associated with the use of hemostasis devices1 to the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) provided the impetus for this study. These devices are...

Reports of serious injuries and...

08/01/2008

Journal of Invasive Cardiology

Risk of Local Adverse Events following Cardiac Catheterization
by Hemostasis Device Use ‚Äî Phase II

08/01/2008

William S. Weintraub , MD, FACC;

Richard E. Shaw , PhD, FACC;

Dale R. Tavris , MD, MPH;

Syamal Dey , MS, PhD;

Beverly Albrecht-Gallauresi , RN, MPH;

Ralph G. Brindis , MD, MPH, FACC;

Kristi Mitchel , MPH;

Reports to the Center for Devices and Radiological Health (CDRH) of the FDA regarding serious injuries and deaths associated with the use of vascular hemostasis devices1 provided the impetus for this study. These devices are used primarily to...

Reports to the Center for...

08/01/2008

Journal of Invasive Cardiology

Bleeding and Vascular Complications at the Femoral Access Site Following Percutaneous Coronary Intervention: An Evaluation of Hemostasis Strategies

10/05/2012

John C. Messenger , MD, FACC, FSCAI;

Dale R. Tavris , MD, MPH;

Beverly Albrecht-Gallauresi , RN, MPH;

Yongfei Wang , MS;

Samantha Jacobs , BS;

Frederic S. Resnic , MD, MSc;

Jeptha Curtis , MD;

Susan Fitzgerald , MS, RN;

Abstract: Background. Previous research found at least one vascular closure device (VCD) to be associated with excess vascular complications, compared to manual compression (MC) controls, following cardiac catheterization. Since that time,...

Abstract: Background. Previous...

10/05/2012

Cath Lab Digest

Original Contribution

Bleeding and Vascular Complications at the Femoral Access Site Following Percutaneous Coronary Intervention (PCI): An Evaluation of Hemostasis Strategies

06/29/2012

Dale R. Tavris , MD, MPH;

Beverly Albrecht-Gallauresi , RN, MPH;

Yongfei Wang , MS;

John C. Messenger , MD, FACC, FSCAI;

Samantha Jacobs , BS;

Jeptha Curtis , MD;